Isotope Cancer Treatment Research at LANL
Abstract
Los Alamos National Laboratory has produced medical isotopes for diagnostic and imaging purposes for more than 30 years. Now LANL researchers have branched out into isotope cancer treatment studies. New results show that an accelerator-based approach can produce clinical trial quantities of actinium-225, an isotope that has promise as a way to kill tumors without damaging surrounding healthy cells.
- Authors:
- Publication Date:
- Research Org.:
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1132883
- Resource Type:
- Multimedia
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND TECHNOLOGY; 60 APPLIED LIFE SCIENCES; MEDICAL IMAGING; CANCER TREATMENT; ACTINIUM-225; MEDICAL ISOTOPES; ALPHA PARTICLES; TUMOR TREATMENT
Citation Formats
Weidner, John, and Nortier, Meiring. Isotope Cancer Treatment Research at LANL. United States: N. p., 2012.
Web.
Weidner, John, & Nortier, Meiring. Isotope Cancer Treatment Research at LANL. United States.
Weidner, John, and Nortier, Meiring. Wed .
"Isotope Cancer Treatment Research at LANL". United States. https://www.osti.gov/servlets/purl/1132883.
@article{osti_1132883,
title = {Isotope Cancer Treatment Research at LANL},
author = {Weidner, John and Nortier, Meiring},
abstractNote = {Los Alamos National Laboratory has produced medical isotopes for diagnostic and imaging purposes for more than 30 years. Now LANL researchers have branched out into isotope cancer treatment studies. New results show that an accelerator-based approach can produce clinical trial quantities of actinium-225, an isotope that has promise as a way to kill tumors without damaging surrounding healthy cells.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2012},
month = {4}
}